The UK company, The Binding Site, partnered with Tecan to automate their innovative multiple myeloma diagnostic method, providing more accurate results and faster access for patients.
Post-mortem RNA sequencing revolutionizes neurological research
Tecan's Trio RNA-Seq kit aids Cerevance in studying neurodegenerative disorders, offering high sensitivity for enhanced disease understanding and drug discovery.
Tecan offers a gold-standard test for Myasthenia Gravis, aiding in early diagnosis and treatment to improve patients' quality of life and health outcomes. Their highly specific biomarkers and targeted assays are instrumental in this effort.